HeartFlow was founded in 2007 by Charles Taylor and Christopher Zarins. Throughout 2021 and 2022, HeartFlow has taken significant steps towards going the public, ultimately deciding to terminate a $2.4 billion SPAC deal in February 2022, citing "current unfavorable market conditions." This is only one recent example of a medical technology company encountering challenges in the SPAC process. These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO.

According to Fierce Biotech, "HeartFlow is developing a test for coronary artery disease that uses deep learning artificial intelligence algorithms to analyze coronary CT angiograms." In March 2022, the company announced that John Farquhar – the former COO, president, and board member – has been appointed CEO. HeartFlow has raised over $530 million in funding from investors including Panorama Point Partners, Wellington Management, Rancilio Cube, and Martis Capital. As of the last funding round, which brought in over $240 million, HeartFlow has arrived at a post-money valuation of $1.5 billion.

Register for Details

For more details on financing and valuation for HeartFlow, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about HeartFlow

Forge green plus iconForge green minus icon

What is HeartFlow's IPO price?

The IPO price for HeartFlow will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in HeartFlow?

HeartFlow is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell HeartFlow shares pre-IPO?

If you own HeartFlow pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is HeartFlow a publicly traded company?

HeartFlow is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

What is HeartFlow's funding to date?

HeartFlow has raised $528.72MM to date.
Forge green plus iconForge green minus icon

When was HeartFlow founded?

HeartFlow was founded in 2007.

Who are HeartFlow's major investors?

Baillie Gifford
Wellington Management
US Venture Partners
Capricorn Investment Group
Bain Capital
Sweetwater Private Equity
Spur Capital Partners
Venture Science
Sandbox Industries
Janus Capital Group
HealthCor Partners Management

HeartFlow Funding Rounds and Last Known Valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation
6/13/2019 Series E $305MM raised $XXX.XX $XXX.XX
5/10/2016 Series D $99.93MM raised $XXX.XX $XXX.XX
2/26/2014 Series C $104.7MM raised $XXX.XX $XXX.XX
2/4/2011 Series B-1 and B-2 $17.05MM raised $XXX.XX $XXX.XX
4/16/2010 Series A $2.04MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: Apr 19, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.